Gubra A/S (CPH:GUBRA)
Denmark · Delayed Price · Currency is DKK 395.80
+2.20 (0.56%)
At close: Mar 5, 2026
Gubra Revenue
In the year 2025, Gubra had annual revenue of 2.64B DKK with 892.25% growth. Gubra had revenue of 144.68M in the half year ending December 31, 2025, with 40.21% growth.
Revenue
2.64B
Revenue Growth
+892.25%
P/S Ratio
2.45
Revenue / Employee
9.59M
Employees
275
Market Cap
6.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.64B | 2.37B | 892.25% |
| Dec 31, 2024 | 265.74M | 60.74M | 29.63% |
| Dec 31, 2023 | 205.01M | 5.62M | 2.82% |
| Dec 31, 2022 | 199.38M | -55.95M | -21.91% |
| Dec 31, 2021 | 255.33M | 83.03M | 48.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| H. Lundbeck | 24.63B |
| Genmab | 23.66B |
| GN Store Nord | 16.78B |
| Zealand Pharma | 9.21B |
| Bavarian Nordic | 6.89B |
| ALK-Abelló | 6.31B |